(Q40226151)

English

Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line.

scientific article published on 29 September 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Irinotecan-cisplatin interactions assessed in cell-based screening assays: cytotoxicity, drug accumulation and DNA adduct formation in an NSCLC cell line (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

0 references

non-small-cell lung carcinoma

1 reference

based on heuristic

inferred from title

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Jason Zastre

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Malathi Anantha

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Euan Ramsay

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

29 September 2006

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

60

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

91-102

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17009029%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

https://scigraph.springernature.com/pub.10.1007/s00280-006-0353-z

0 references

Paclitaxel and SN-38 overcome cisplatin resistance of ovarian cancer cell lines by down-regulating the influx and efflux system of cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS00280-006-0353-Z

21 January 2018

Synergistic enhancement of cisplatin cytotoxicity by SN-38, an active metabolite of CPT-11, for cisplatin-resistant HeLa cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-006-0353-Z

21 January 2018

Determinants of CPT-11 and SN-38 activities in human lung cancer cells

1 reference

https://api.crossref.org/works/10.1007%2FS00280-006-0353-Z

21 January 2018

Influence of low pH on cytotoxicity of paclitaxel, mitoxantrone and topotecan

1 reference

https://api.crossref.org/works/10.1007%2FS00280-006-0353-Z

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40226151&oldid=1672505818"